Press Releases
Stevanato Group signs an agreement with COLANAR for lab-scale fill & finish capabilities
Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for drug delivery systems has signed an agreement with COLANAR, a global leader in small-batch pharma filling machines.
Stevanato Group's new US Technology Excellence Center...
Press Releases
Thermo Fisher Scientific Launches Industry-Leading Offering to Facilitate cGMP-Compatible Cell and Gene Therapy Manufacturing
Thermo Fisher Scientific announces the launch of an industry-leading product, compliance and services portfolio, compatible with current Good Manufacturing Practice (cGMP) and designed to enable rapid start-up of clinical and commercial cell and gene therapy manufacturing.
Developed as the first-ever...
Drug Research
CMIC Group Establishes a New Biologic Contract Development and Manufacturing Business in Japan
CMIC HOLDINGS Co., Ltd. announced the establishment of CMIC BIO Co., Ltd. (hereafter CMIC BIO), a fully-owned subsidiary that offers Contract Development and Manufacturing Organization (hereinafter CDMO) services for biopharmaceutical drug substance. CMIC Bio has a single-use facility in...
Packaging & Labelling
Perlen Packaging announces the launch of the innovation PERLALUX-MultiLayer ultra 280
Perlen Packaging is expanding its product range for pharmaceutical blister films with the innovation - PERLALUX®- MultiLayer ultra 280. Thanks to its smart design, the new ultra-high barrier PVdC film should be universally applicable and has optimised processing properties.
Perlen...
Drug Research
CEPI expands partnership with Clover to rapidly advance development and manufacture of COVID-19 vaccine candidate
CEPI, the Coalition for Epidemic Preparedness Innovations, announced the expansion of its partnership with Sichuan Clover Biopharmaceuticals, Inc to rapidly advance the development and manufacture of Clover’s protein-based COVID-19 S-Trimer vaccine candidate, which is based on Clover’s proprietary Trimer-Tag©...
Press Releases
BD Partners with U.S. Government on $70 Million Manufacturing Infrastructure Project for Mass Vaccination Campaigns
BD, a leading global medical technology company announced the formation of a strategic, public-private partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Health and Human Services Office of the Assistant Secretary for Preparedness...
Clinical Trials
ACTC, Eisai & Biogen announce initiation of new phase III clinical study of BAN2401 for preclinical Alzheimer’s disease
The Alzheimer's Clinical Trials Consortium , Eisai Co., Ltd and Biogen Inc announced that a new phase III clinical study (AHEAD 3-45) of BAN2401, an anti-amyloid beta (Aß) protofibril antibody, has been initiated in the United States of America...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read